Lilly's Cialis approved for benign prostatic hyperplasia

INDIANAPOLIS — The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday.



The FDA approved Cialis (tadalafil) as a once-daily treatment for men with erectile dysfunction and benign prostatic hyperplasia, also known as BPH, as well as for BPH alone. BPH is a condition in which the prostate enlarges, which can cause urinary symptoms.



"Since many men who have ED also experience the signs and symptoms of BPH, a single medication approved to treat both may be a significant therapeutic option for men and physicians," University of Texas Southwestern Medical Center Department of Urology chairman Claus Roehrborn said. "The FDA approval of Cialis for once-daily use for the treatment of ED and the signs and symptoms of BPH provides a new option that allows men to treat both with one daily medication."

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.